Marco Boorsma

	Sneek Netherlands

	Forbion Director Forbion Capital Partners Partner at Forbion General Partner Escalier Biosciences Prexton Inflazome Raises

Images of Marco Boorsma

(0 from 0 )

News

(1 - 4 from 14

–show all

)

Dezima Pharma raises €14.2m ($18.6m) to develop its CETP inhibitor...

lifesciences.instinctif.com

Marco Boorsma of Forbion Capital Partners, Somu Subramaniam of New Science Ventures, and Wil Hazenberg of BioGeneration Ventures will ...

Forbion Capital Partners Announces First Close of FCF III -...

lifesciences.instinctif.com

... Holger Reithinger, Christina Takke and Marco Boorsma. This team has worked together for over a decade and combines entrepreneurial, ...

Escalier raises $19m to fund novel psoriasis pill - Pharmaphorum

pharmaphorum.com

... of developing novel compounds targeting diseases with significant unmet medical need,” stated Marco Boorsma, General Partner at Forbion, ...

Klim Classic | Côte de la Redoute (mannen) Pos ...

upload.mysports.tv

2752 Marco Boorsma. NED ,98 0:06: , Aart van Wijk. NED ,54 0:06: , Ray Klöters. GER ,41 0:06:13.

Telephone & Addresses

Marco boorsma Kesteren - Telefoonboek.nl - telefoongids bedrijven

www.telefoonboek.nl

Marco boorsma Kesteren op Telefoonboek.nl - Naast een marco boorsma vind je ook bouw, hout, kleding, loonbedrijven, markthandel

Network Profiles

(1 - 4 from 9

–show all

)

Facebook: Marco Boorsma - Is heel Gooiland open met oud en nieuw of ...

Facebook: Marco Boorsma Profiles | Facebook

LinkedIn: Marco Boorsma | LinkedIn

Marco Boorsmas berufliches Profil anzeigen LinkedIn ist das weltweit größte berufliche Netzwerk, das Fach- und Führungskräften wie Marco Boorsma dabei hilft ...

LinkedIn: Marco Boorsma | LinkedIn

Bekijk het professionele profiel van Marco Boorsma op LinkedIn. LinkedIn is het grootste zakelijke netwerk ter wereld en stelt professionals als Marco Boorsma ...

Interests

(1 - 4 from 7

–show all

)

Escalier Biosciences Raises $19 Million to Develop Markets Insider

markets.businessinsider.com

... diseases with significant unmet medical need," stated Marco Boorsma, General Partner at Forbion who will join Escalier's Board of Directors.

Federal Corporation Information Online Filing Centre ...

www.ic.gc.ca

Canada; Marco Boorsma It Harspit VS Sneek Netherlands; Steven Gannon Saint-Patrick Street Apt Montréal QC H3K 3G9 Canada; Dennis ...

Marco Boorsma - Patents

www.freshpatents.com

Marco Boorsma patents Recent bibliographic sampling of Marco Boorsma patents listed/published in the public domain by the USPTO (USPTO Patent Application #,Title):

Dublin-headquartered Inflazome completes €40m funding round ...

www.independent.ie

... we intensively screened the universe of companies active in this space," Dr Marco Boorsma, general partner at Forbion Capital Partners, said ...

Business Profiles

Education

ESN Zürich

zurich.esn.ch

Erasmus Student Network Zürich - The aims of ESN are to promote the social and personal integration of the students who spend part of their studies at a...

Property

WO A2 - Inducible alphaviral/orip based gene expression...

patents.google.com

The present invention relates to compositions and methods that allow the production of polypeptides and untranslated RNA molecules in host cells. More...

Books & Literature

(1 - 4 from 7

–show all

)

Marco Boorsma | XanEdu Customization Platform

www.academicpub.com

Author: Marco Boorsma. Results. New applications of alphavirus-based expression vectors Springer Science+Business Media By: Marco ...

Animal Cell Technology: From Target to Market - European Society of...

books.google.de

This book is the lasting product, a resource of up-to-date information in the scientific literature for the field of animal cell technology, as it was...

Animal Cell Technology: From Target to Market: Proceedings of the...

books.google.es

Proceedings of the 17th ESACT Meeting June , 2001, Tylösand, Sweden

Animal Cell Technology: Products from Cells, Cells as Products:...

books.google.es

Proceedings of the 16th ESACT Meeting, April , 1999, Lugano, Switzerland

Scientific Publications

Escalier Biosciences Scores $19 Million in Funding Supporting ...

marketscale.com

... diseases with significant unmet medical need,” stated Marco Boorsma, general partner at Forbion who will join Escalier's board for financing.

Publications

Video & Audio

Gute Nachrichten auf dem BioM-Finanzierungs-Forum: Europäische...

www.bio-m.org

Die Partner Geert-Jan Mulder, Holger Reithinger, Christina Takke und Haupt Marco Boorsma werden das Portfolio des Fonds verwalten.

Reports & Statements

Building for big pharma - Nature

www.nature.com

Asiya Giniatullina, Marco Boorsma, Geert-Jan Mulder & Sander van Deventer. With acquisition the most likely exit for today's biotech investors, it pays to keep ...

Miscellaneous

(1 - 20 from 46

–show all

)

Marco Boorsma | LinkedIn

www.linkedin.com

Marco Boorsma. Marketing & communicatie at de Alliantie. Location Almere Stad Area, Netherlands Industry Marketing and Advertising

Marco Boorsma | LinkedIn

www.linkedin.com

View Marco Boorsma's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Marco Boorsma discover ...

Marco Boorsma | LinkedIn

www.linkedin.com

Marco Boorsma. Events & Congres at Landgoed Zonnestraal Location Almere Stad Area, Netherlands Industry

WO A1 - Selection of human monoclonal antibodies by...

patents.google.com

9, *, MARCO BOORSMA ET AL: "New applications of alphavirus-based expression vectors" CYTOTECHNOLOGY, KLUWER ACADEMIC PUBLISHERS, DO, vol.

DE T Inducing alphavirengen- expression system - Google...

patents.google.com

Inventors, A Renner, Lars Nieba, Marco Boorsma. Applicant, Cytos Biotechnology Ag Zuerich, Renner Wolfgang Andreas, Lars Nieba, Marco Boorsma.

Stream Marco Boorsma music | Listen to songs, albums, playlists for...

soundcloud.com

Play Marco Boorsma and discover followers on SoundCloud | Stream tracks, albums, playlists on desktop and mobile.

Genealogie lijst voor de provincie Groningen. - Yahoo Groups

groups.yahoo.com

Familieberichten Sneeker Nieuwsblad Geboorte: Nina Maaike d.v. Marco BOORSMA en Tynke BAKKER, Groningen

Marco Boorsma, Ph.D. - Escalier Biosciences

www.escalierbio.com

Marco Boorsma, Ph.D. Marco is a General Partner at Forbion Capital Partners. He has a background in molecular biology and biotechnology and brings operational and business development experience from both small and large businesses.

Inflazome Completes €40m ($46m) Series B Financing to Develop ...

finance.yahoo.com

Following the completion of the financing round, Dr Marco Boorsma, a General Partner at Forbion, and Dr David Hirsch, a Managing Director ...

Marco Boorsma | RSPR | Sweden - OMICS International

biography.omicsonline.org

Marco Boorsma. PhD. Oncology RSPR Sweden. Marco Boorsma. Biography. Marco is Partner at Forbion Capital Partners investing in Life Science companies.

PharmaTelevision - Marco Boorsma describes Forbion Capital Partners’...

www.pharmatelevision.com

Marco Boorsma describes Forbion Capital Partners' investment strategy and gives his personal perspective on the future of the Biotech sector ...

www.infona.pl

Marco Boorsma, Daniel Koller, Wolfgang Renner, Martin Bachmann · Cytotechnology 35 , 3 , Alphaviruses are positive stranded RNA viruses ...

Hardloopprofiel van Marco Boorsma

www.schaatsapp.nl

Alle hardlooptijden, statistieken en persoonlijke records van Marco Boorsma.

Marco Boorsma - PokerCity – Live Reporting & Poker Nieuws

www.pokercity.nl

WaSOP X Namur: Fransman Nicolas Plantin wint High Roller, Jorden Verbraeken tweede. In de schaduw van de gigantische opkomst in het Main Event ...

Marco Boorsma | Fundwijzer crowdfunding

www.fundwijzer.nl

Het jonge biotechbedrijf Escalier Biosciences heeft $19 mln (ruim €15 mln) opgehaald voor de ontwikkeling van een geneesmiddel tegen ...

Board of Directors - Escalier Biosciences

www.escalierbio.com

Marco Boorsma, Ph.D. General Partner at Forbion Capital Partners. Marco is a General Partner at Forbion Capital Partners. He has a background in molecular biology and biotechnology and brings operational and business development experience from both small and large businesses.